Better Data Visibility and Data Use Result in Lower Cost and Improved Performance in Medicine Supply...
-
Upload
jsi -
Category
Health & Medicine
-
view
87 -
download
0
Transcript of Better Data Visibility and Data Use Result in Lower Cost and Improved Performance in Medicine Supply...
![Page 1: Better Data Visibility and Data Use Result in Lower Cost and Improved Performance in Medicine Supply Chains](https://reader031.fdocuments.in/reader031/viewer/2022030315/587ff77c1a28ab3a1e8b5375/html5/thumbnails/1.jpg)
BETTER DATA VISIBILITY & DATA USE
RESULT IN LOWER COST AND IMPROVED
PERFORMANCE IN MEDICINE SUPPLY
CHAINS
Bloomberg Data for Good Exchange
Presented by Cary Spisak
![Page 2: Better Data Visibility and Data Use Result in Lower Cost and Improved Performance in Medicine Supply Chains](https://reader031.fdocuments.in/reader031/viewer/2022030315/587ff77c1a28ab3a1e8b5375/html5/thumbnails/2.jpg)
Public health programs are reliant on
well-performing supply chains
to deliver life-saving commodities
to patients in need
![Page 3: Better Data Visibility and Data Use Result in Lower Cost and Improved Performance in Medicine Supply Chains](https://reader031.fdocuments.in/reader031/viewer/2022030315/587ff77c1a28ab3a1e8b5375/html5/thumbnails/3.jpg)
With limited funding, what management and
technology investments can be cost-effective
and have a transformative effect on the
performance of the supply chain for health
commodities?
THE KEY QUESTION
![Page 4: Better Data Visibility and Data Use Result in Lower Cost and Improved Performance in Medicine Supply Chains](https://reader031.fdocuments.in/reader031/viewer/2022030315/587ff77c1a28ab3a1e8b5375/html5/thumbnails/4.jpg)
TANZANIA CONTEXT
With limited funding,
what management and
technology investments
can be cost-effective and
have a transformative effect
on the performance of the
supply chain for health
commodities?
Logistics
Management Unit
(LMU)
Electronic MIS for
commodity logistics
(eLMIS)
ExistIng System Intervention Objectives
• Fragmented supply system
• Uncoordinated management
• Largely paper-based MIS
• Data of poor quality and
availability
Leading to…
• Poor stock availability
• Low client service levels
• High costs
• Coordinate, monitor and
support to manage the supply
chain for the various health
programs
• Consolidate electronic and
paper-based systems
• Improve data visibility,
accuracy, quality, timeliness
MOHCDGEC: Is the existing system cost-effective? Where might the new system drive
cost savings and performance improvements?
![Page 5: Better Data Visibility and Data Use Result in Lower Cost and Improved Performance in Medicine Supply Chains](https://reader031.fdocuments.in/reader031/viewer/2022030315/587ff77c1a28ab3a1e8b5375/html5/thumbnails/5.jpg)
METHODOLOGY
Data Collection Indicators
• Baseline Aug – Oct 2013
• Year 1 performance
Apr – May 2015
• Data from 3 major
existing systems:
• Essential medicines
• ARVs/ HIV
• Immunization/ EPI
• Supply chain performance
• Reporting
• Data use
• Management practices
• Supply chain outcomes
• Cost
• Operations by function
and tier
• Commodity throughput
• Data from nationally
representative sample
of facilities and districts
including Medical
Stores Dept
• Cost and performance
data from existing
surveys and databases
![Page 6: Better Data Visibility and Data Use Result in Lower Cost and Improved Performance in Medicine Supply Chains](https://reader031.fdocuments.in/reader031/viewer/2022030315/587ff77c1a28ab3a1e8b5375/html5/thumbnails/6.jpg)
RESULTS: IMPROVED STOCK AVAILABIL IT Y
STOCK OUT RATE STOCK OUT DURATION
23%
27%
40%
32%
39%
19%
23% 25%
22%
10%
15%
20%
25%
30%
35%
40%
45%
EPI ARV Essentialmeds
FamilyPlanning
Malaria
BaselineRound 1
26%
23%
37%
16%
32%
12%
24%
13%
22%
10%
15%
20%
25%
30%
35%
40%
45%
EPI ARV Essentialmeds
FamilyPlanning
Malaria
BaselineRound 1
Pe
rce
nt
of
facilit
ies s
tock
ed
ou
t o
n
da
y o
f vi
sit
Pe
rce
nt
of
facilit
ies s
tock
ed
ou
t >
7 d
ays
Product Group Product Group
32%
23% Round 1
Baseline AVERAGE ACROSS
COMMODITIES
95% Confidence Interval
24%
15% Round 1
Baseline AVERAGE ACROSS
COMMODITIES
95% Confidence Interval
![Page 7: Better Data Visibility and Data Use Result in Lower Cost and Improved Performance in Medicine Supply Chains](https://reader031.fdocuments.in/reader031/viewer/2022030315/587ff77c1a28ab3a1e8b5375/html5/thumbnails/7.jpg)
Annual Operating Cost
Value of Handled Commodities
Cost per Value of Commodities
Supply Chain Performance
Cost per Value of Commodities,
Adjusted for Performance
Baseline $59m
Baseline $208m
Baseline 28%
Baseline 68%
Baseline 42%
Round 1 $63m
Round 1 $251m
$63m
$251m
Round 1 25% 25%
Round 1 77%
Round 1 31%
77%
31%
RESULTS: IMPROVED PERFORMANCE
![Page 8: Better Data Visibility and Data Use Result in Lower Cost and Improved Performance in Medicine Supply Chains](https://reader031.fdocuments.in/reader031/viewer/2022030315/587ff77c1a28ab3a1e8b5375/html5/thumbnails/8.jpg)
• System enhancements had positive impact on supply
• Higher costs but also gains in efficiency
However…
• Results may be fragile – are gains sustainable?
• Little movement for some indicators
• Establishing robust systems is critical step but must be
built into system as part of routine decision making and
culture of continuous improvement
INTERPRETATION
![Page 9: Better Data Visibility and Data Use Result in Lower Cost and Improved Performance in Medicine Supply Chains](https://reader031.fdocuments.in/reader031/viewer/2022030315/587ff77c1a28ab3a1e8b5375/html5/thumbnails/9.jpg)
For more information about
JSI’s work in supply chain, data
visibility, and data use, contact the
JSI Center for Health Logistics
Follow @jsihealth